Skip to main content
Search
Menu
About
Leadership
Preclinical Reproducibility
Innovation
Comprehensive Translational Pathway
Device Innovation
Drug Development
Innovative Animal Models
Regulation
Resources
Biostatistics
GLP Compliance
Data Integrity and Traceability
Optical Molecular Imaging and Analysis
Inhalation and Respiratory Therapy
Irradiator and Radiation Therapy
Pathology
PK/PD Lab
Regulatory Support
Sequencing and Genomic Technologies
Surgical Expertise
News
Press Releases
Partners
Contact
Staff
Leadership
Dr. Greg Palmer
– Chief Director
Dr. Gabi Hanna
– Chief Executive Officer
Advisors
Mark Stacy, M.D.
, Vice Dean for Clinical Research
Robin L. Rasor
, Duke OLV- Executive Director
Mark Dewhirst, D.V.M., Ph.D.
, Gustavo S. Montana Professor of Radiation Oncology.
Steven Patierno, Ph.D.
, Deputy Director of the Duke Cancer Institute (DCI).
Dr. Eric J. Toone
, leader of the Duke Innovation and Entrepreneurship Initiative.
Dr. John Norton
Bruce K. Burnett Ph.D
Herbert Ira Hurwitz, M.D.
Jiaoti Huang
, Endowed Department Chair of Pathology.
Leadership
Preclinical Reproducibility